OncoTribune Contents

OncoTribune コンテンツ紹介

学会速報レポート

Congress Report

海外学会などで発表されたホットでタイムリーな演題を専門医が厳選。レポートとコメントを掲載します。

臨床試験サマリ

Executive Summary of Cancer Clinical Trials

各領域で発表されている臨床試験を分かりやすくサマライズして掲載します。

座談会

Round Table Discussion

各領域のエキスパートによるディスカッションした内容を掲載します

Latest Updates

新着コンテンツ

ASCO-GI 2020 FLASH REPORT - Abstract 476 - 肝胆膵癌 Oral

Patient-reported outcomes (PROs) from the Phase III IMbrave150 trial of atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) as first-line treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC).
First Author: Peter R. Galle, MD, PhD

ASCO-GI 2020 FLASH REPORT - Abstract 5 - 大腸癌 Oral

Utility of circulating tumor DNA (ctDNA) versus tumor tissue clinical sequencing for enrolling patients (Pts) with advanced gastrointestinal (GI) cancer to matched clinical trials: SCRUM-Japan GI-SCREEN and GOZILA Combined Analysis.
First Author: Yoshiaki Nakamura

ASCO-GI 2020 FLASH REPORT - Abstract 281 - 食道癌 Oral

A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.
First Author: Maarten C.C.M. Hulshof, MD PhD

ASCO-GI 2020 FLASH REPORT - Abstract 100 - 大腸癌 Poster

VOLTAGE-B study: Nivolumab monotherapy and subsequent curative surgery following preoperative chemoradiotherapy in patients with locally recurrent rectal cancer (LRRC) without previous radiotherapy.
First Author: Takeshi Kato, MD, PhD

ASCO-GI 2020 FLASH REPORT - Abstract 478 - 肝胆膵癌 Oral

Nivolumab (NIVO) + ipilimumab (IPI) + cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
First Author: Thomas Yau

ASCO-GI 2020 FLASH REPORT - Abstract 7 - 大腸癌 Oral

A randomized phase III trial comparing primary tumor resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 study (iPACS).
First Author: Yukihide Kanemitsu, MD

ASCO-GI 2020 FLASH REPORT - Abstract 374 - 胃癌 Poster

An open-label phase II study of lenvatinib plus pembrolizumab in patients with advanced gastric cancer (EPOC1706).
First Author: Akihito Kawazoe

ASCO-GI 2020 FLASH REPORT - Abstract 383 - 胃癌 Poster

A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data.
First Author: Li-Tzong Chen, MD, PhD

ASCO-GI 2020 FLASH REPORT - Abstract 178 - 大腸癌 Poster

Plasma VEGF-D and PlGF levels according to prior use of biologics among metastatic colorectal cancer: Preliminary results from GI-SCREEN CRC-Ukit study.

肝細胞癌 REFLECT

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

Kudo M, Finn RS, Qin S. et al. Lancet 2018; 391: 1163-73.